ACAD (acadia-pharm.com) Sof foyda

acadia-pharm.com (ACAD) kompaniyasining rasmiy ramzlari

ACADIA Pharmaceuticals (ACAD) noyob psixiatrik kasalliklar uchun mo'ljallangan dori vositalarining narxini belgilashda monopol narx belgilash vakolatiga ega. Tashkilotning sof foydasi moliyaviy barqarorlikni namoyish etmoqda va uning qiymati 0.38 miqdorida belgilangan. Foyda o'sishi FDA ning qat'iy nazorati va ishlab chiqishning yuqori xarajatlari bilan ta'minlanadi, ekologik strategiya esa etik tadqiqotlar va laboratoriya energiya samaradorligiga asoslangan.

ACADIA Pharmaceuticals Inc (ACAD): Sof foyda 04.07.2022dan 29.10.2026gacha

ACADIA Pharmaceuticals Inc. (ACAD) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi ACADIA Corp|ACAD - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi ACADIA Corp|ACAD - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun buxgalteriya qiymati ACADIA Pharmaceuticals|ACAD - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati acadia-pharm.com|ACAD - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati ACADIA Pharmaceuticals|ACAD - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti ACADIA Pharma|ACAD - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar ACADIA Corp|ACAD - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari ACADIA Pharmaceuticals|Kritik likvidlik koeffitsiyenti acadia-pharm.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ACAD - Sof foyda
Fundamental baholash:ACADIA Pharmaceuticals
ACADIA Pharmaceuticals Inc brendining mahsuloti

ACADIA Pharmaceuticals (ACAD) kompaniyasining fundamental barqarorligini bozor shovqinlaridan ajratish uchun barcha operatsion va soliq xarajatlaridan tozalangan yakuniy moliyaviy natijani tahlil qilish zarur. Kompaniyaga tegishli sof sof foyda tendentsiyasi biznesning nevrologiya sohasidagi ulkan R&D xarajatlarini yengib chiqish va o'z patent monopoliyasini monetizatsiya qilish, ya'ni xavfli klinik ishlanmalarni barqaror pul oqimiga aylantirish qobiliyatini aks ettiradi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof foyda regencellbioscience.com|Sof foyda AXSM|Sof daromad Xenon Pharmaceuticals Inc. XENE|Sof foyda VKTX (Viking Pharma)|Sof foyda Supernus Corp SUPN|Catalyst Pharmaceuticals - Sof foyda|DNLI (denalitherapeutics.com) - Kompaniya foydasi|HRMY: Sof foyda|BHVN - Sof moliyaviy natija|AMLX (Amylyx) - Sof foyda|Sof foyda Trevi Corp|Sof daromad PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Yakuniy foyda|Kompaniyaning sof foydasi CeriBell CBLL|PRTA (Prothena Corp) - Soliqdan keyingi foyda|Alector Therapeutics - Sof foyda|Yakuniy foyda ANNX (Annexon Biosciences Inc.)|OMER: Sof foyda|neurogene.com (NGNE) - Sof foyda|Kompaniyaning sof foydasi AC Immune SA|VYGR: Yakuniy foyda|Kompaniyaning sof foydasi Neumora Therapeutics Inc (NMRA)|Sof daromad Scilex Holding Company, Inc. SCLX|Sof foyda TVGN (Tevogen Bio Holdings)|Sof foyda Alpha Cognition Inc ACOG|Cognition Therapeutics - Sof foyda|Inhibikase Therapeutics Inc (IKT) - Sof daromad|SAVA: Sof foyda|Kompaniyaning sof daromadi Assertio (ASRT)|Sof daromad COYA|Sof foyda VistaGen Therapeutics Inc|Sof daromad OVID (Ovid Therapeutics Inc.)|Soliqlar to‘langandan keyingi foyda ABOS|Sof foyda CRVO (CervoMed Inc)|Sof moliyaviy natija Alterity Therapeutics Ltd. (ATHE)|Clene Nanomedicine - Sof foyda|PepGen Inc. (PEPG) - Sof daromad|JUNS: Sof foyda|Relmada Therapeutics Inc (RLMD) - Sof foyda|Kompaniyaning sof foydasi Annovis Bio Corp|Kompaniyaning sof foydasi GRCE|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof moliyaviy natija anewmeds.com|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Sof foyda Reviva Pharmaceuticals Holdings Inc. RVPH|MetaVia, Inc. - Sof foyda|NeurAxis Inc (NRXS) - Sof daromad|HSDT: Sof foyda|Passage Bio (PASG) - Sof foyda|NEUP (Neuphoria Therapeutics, Inc.) - Sof foyda|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Kompaniyaning sof foydasi Athira (ATHA)|Addex - Kompaniya foydasi|Sof foyda ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|PTIX: Sof daromad|KTTA - Sof foyda|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Avenue Therapeutics Inc - Yakuniy foyda|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniyaning sof daromadi caratherapeutics.com CARA|Sof foyda CHRO|Sof foyda eliemtx.com (ELYM)|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|LBPH - Sof daromad|Marinus Pharmaceuticals - Sof foyda|NKGN - Sof foyda|NRBO: Sof foyda|Kompaniya foydasi SAGE|SNPX (Neurotrope) - Sof foyda|Trevena Inc (TRVN) - Sof moliyaviy natija|Sof foyda VIGL|Sof foyda Anew Medical Inc. (WENA)|Cerevel Therapeutics, Inc. - Sof daromad